Besifloxacin and the management of corneal graft infections: A review of current evidence
I recently came across a review discussing the role of Besifloxacin in managing corneal graft infections. From the current evidence, it appears that Besifloxacin, a fluoroquinolone antibiotic, is quite effective in treating these infections. It works by targeting the bacterial enzymes responsible for DNA replication, thus stopping the infection from spreading. Additionally, its unique chemical structure makes it less likely for bacteria to develop resistance. Overall, Besifloxacin seems to be a promising option for managing corneal graft infections and ensuring the success of transplantations.
